NIHR Manchester Biomedical Research Centre

Greater Manchester has a deep heritage in science, innovation and entrepreneurship.

The NIHR Manchester Biomedical Research Centre (BRC) connects world-leading researchers based at The University of Manchester and three NHS Trusts in Greater Manchester, with a joint vision to drive forward the transformation of scientific breakthroughs into life-saving treatments and care for patients.

Clinical leaders appointed to drive innovation across Greater Manchester

Posted: Tuesday, December 4, 2018

Health Innovation Manchester has strengthened its leadership team with two key appointments including Professor Ian Bruce as Research Director.

Role of protease targets in wound healing uncertain

Posted: Monday, December 3, 2018

Protease modulating therapies are used to assist in venour leg ulcer closure, but a recent review suggests that physicans should rexamine the biomarker's role in targeted chronic wound healing therapies.

View More News

Introducing the NIHR Manchester BRC

We will drive forward pioneering research into new tests and treatments in musculoskeletal disease, hearing health, respiratory disease, dermatology and three cancer themes (prevention, radiotherapy and precision medicine), utilising our expertise in biomarkers, informatics and the rapid translation of research findings.

You can help shape our research

There are plently of opportunities for people to help shape our research plans. Research is vital to help us understand more about a particular disease or condition and how to treat them.

Recent Blog Articles

Recognising the importance of COPD awareness and research

Posted: Wednesday, November 21, 2018 Author: Professor Jorgen Vestbo

On World COPD Day, Professor Jørgen Vestbo, Respiratory Theme Lead and COPD Programme Co-Lead for Manchester BRC, reflects on the status and management of COPD and reminds us that we shouldn’t overlook this devastating disease.

Posted: Thursday, November 15, 2018 Author: Dr Alexander Mathioudakis

During World Antibiotic Awareness Week, Dr Alexander Mathioudakis, BRC Clinical Fellow discusses how the TRACE-COPD trial is using blood tests to guide and target the administration of antibiotics and oral steroids.

Opportunities for partnership working

We’re looking to build collaborations with industry, public and charity partners to deliver on our ambitious plans.

The development of new clinical tests and treatments requires significant investment, specialist facilities and a diverse skillset, only made possible through a collaborative approach.